Zdrowie i gospodarka · 21/07/2022
FDA Clears XYLOCAINE Topical Solution 4% for Continued Sale
The US Food and Drug Administration has ruled that XYLOCAINE (lidocaine hydrochloride) topical solution 4% was not withdrawn from the market due to safety or efficacy concerns, allowing it to remain available for prescription.
Source: Federal Register — Food and Drug AdministrationOpen original release →